Artificial Intelligence (AI) in Cancer Market to Grow at a CAGR of 23.1% | PR Newswire [Video]

“Report Highlights Market Growth Propelled by Rising Cancer Rates and AI in Drug Discovery, with Breast Cancer Segment Growing at 21.8% Due to Improved Screening and Early Diagnosis”

, /PRNewswire/ — According to the latest study from BCC Research, “Artificial Intelligence (AI) in Cancer” is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.

The report explores AI technology’s current and future potential in cancer applications, considering market drivers, restraints, and opportunities. It includes projections through 2029 and examines the competitive landscape. In this report, the market is segmented by application (screening, diagnosis, therapy, drug discovery, etc.), cancer type (breast, lung, prostate, etc.), and end-user (hospitals, diagnostic centers, etc.). It covers the regions of North America, Europe, Asia Pacific, and the Rest of the World. Company profiles offer insights into their business segments, financials, and recent developments.

This report is …